Ruxolitinib and Pracinostat Combination Therapy for Patients With Myelofibrosis (MF)
Clinical trial NCT02267278 · COMPLETED
Trial details
- NCT number
- NCT02267278
- Sponsor
- M.D. Anderson Cancer Center
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2015-01-12
- Primary completion
- 2018-06-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.